Network connection error 4712....
Test Definition
Test Definition
Test Test Description To Print Test Code Unit QC Cost Result Type Round off Numeric Result Type Assay Content Microbial Retest Test for Water/LOD
# 100 0 Character N N N
# 20 mesh 0 Character N N N
#200 mesh 0 Character N N N
#60 mesh 0 Character N N N
% Single Maximum unknown impurity: 0 Character N N N
% Total unknown impurity: 0 Character N N N
(a) By Light Obscuration Particle Count Test ≥ 10µm 0 Character N N N N
(a) Sulbactam 0 Character N N N N
(b) By Light Obscuration Particle Count Test ≥ 25µm 0 Character N N N N
(b) Cefoperazone 0 Character N N N N
(on anhydrous basis) 0 Character N N N
(on as is basis) 0 Character N N N
*Ink lifting test 0 Character N N N
-RRT 0.86 0 Character N N N
-RRT 1.27 0 Character N N N
-RRT 1.39 0 Character N N N
-RRT > 2.0 0 Character N N N
. p- toluene sulphonamide 0 Character N N N
1) Lidocaine Hydrochloride BP: 10.0 mg/mL 0 Character N N N
1)Diethylene glycol 0 Character N N N
1,4 Dioxane 0 Character N N N N
1-vinylpyrrolidin-2-one 0 Character N N Y
12- hydroxyl stearic acid 0 Character N N N
12-oxosteric acid 0 Character N N N
2) Ethylene glycol 0 Character N N N
2) Sodium Chloride BP: 7.0 mg/mL 0 Character N N N
2,6 Dimethylaniline 0 Character N N N
2- Ethylhexanoic acid by GC 0 Character N N N
2-Hydroxy-2-methyl-proplophenone (2-HMP) 0 Character N N N N
2-methylbut -2-ene 0 Character N N N
2-Propanol 0 Character N N N
2-Pyrrolidone 0 Character N N N
28.5 ml to 31.5 ml 0 Character N N N
2D Code 0 Character N N N
3) Methyl Paraben BP: 1.0 mg/mL 0 Character N N N
45MIC x 300MM LDPE SHRINK FILM 0 Character N N N
5 Ply C/Box 410X280X215 Oflox -D 0 Character N N N
5-Benzyl-3,6-dioxo-2-piperazineacetic acid 0 Character N N N
6- Bromopenicillanic Acid Sulphone 0 Character N N N
7-Aminocephalosporanic acid (if present) 0 Character N N N
A Assay (Initial): by HPLC Each 5 ml reconstituted suspension contains:Cefixime IP (as Trihydrate) equivalent to Anhydrous Cefixime 100 mg. 0 Character N N N
A NLT 75% (D) i.e 80 % of the stated amount of Cefixime released in 45 min. 0 Character N N N
A ) Assay (in %) (Each vial contains: Ceftriaxone Sodium Eq. to Ceftriaxone 0 Numeric Range N N N
A ) By chemically 0 Character N N N
A) 0 Character N N N
A) A)When sample is strongly heated becomes pale yellow, the colour discharge on cooling. 0 Character N N N
A) Assay (Initial): by HPLC 0 Character N N N
A) Assay (Initial): by HPLC Each 5 ml reconstituted suspension contains:Cefixime IP (as Trihydrate) equivalent to Anhydrous Cefixime 100 mg. 0 Character N N N
A) By IR 0 Character N N N
A) Cefixime 0 Character N N N
A) Cefixime released in 45 min. 0 Character N N N
a) 2.5 ml marking 0 Character N N N
A) Assay (Initial): Each 5 ml reconstituted suspension contains: Cefixime Trihydrate IP equivalent to Cefixime anhydrous 50 mg 0 Character N N N
A) Assay (Initial): Cephalexin IP equivalent to anhydrous Cephalexin 125 mg. 0 Character N N N
A) Assay (Initial):Each 5 ml of the reconstituted suspension contains:Cefixime IP as Trihydrate equivalent to anhydrous Cefixime 100 mg. 0 Character N N N
A) Average net volume 0 Character N N N
A) By Banzoates 0 Character N N N
A) By Colour test 0 Character N N N
A) By Freezing point 0 Character N N N
A) By HPLC 0 Character N N N
A) By IR 0 Character N N N
A) By IR (method I) 0 Character N N N
A) By Magnesium test 0 Character N N N
A) By microscopy 0 Character N N N
A) By Relative density 0 Character N N N
A) By Specific rotation 0 Character N N N
A) By TLC 0 Character N N N
A) By UV 0 Character N N N
A) By visual inspection 0 Character N N N
A) By visual test 0 Character N N N
A) Chloride Test 0 Character N N N
A) Clarity with water 0 Character N N N
A) Escherichia coli 0 Character N N N
A) Freezing point 0 Character N N N
A) I- Indication for a polymeric compound 0 Character N N N
a) Less than 0.5 % Particles should retain on #60 mesh ASTM (250µm) 0 Character N N N
A) Melting point 0 Character N N N
A) NLT 50 % (Q) i.e 55 % of the labeled amount of cefuroxime released in 15 min. 0 Character N N N
A) Sulbactam (activity) 0 Character N N N N
A) Total aerobic microbial count 0 Character N N N
A)1 For Cefixime % Single Maximum Impurity: 0 Character N N N
A)2 For Cefixime % Total Impurities: 25 250 Character Y Y Y
A)Assay (Initial): by HPLC Cefixime USP (as Trihydrate) equivalent to Anhydrous Cefixime 50 mg. 0 Character N N N
A)Assay (Initial): by HPLC Each 5 ml reconstituted suspension contains: Cefixime Trihydrate IP equivalent to Cefixime anhydrous 50 mg. 0 Character N N N
A)Assay (Initial): by HPLCEach 5 ml reconstituted suspension contains: Ofloxacin IP 50 mg: 0 Character N N N
A)Assay (Initial): Cefpodoxime Proxetil IP equivalent to Cefpodoxime 50 mg.. 0 Character N N N
A)Assay by HPLCEach 5 ml of the reconstituted suspension contains:Cefpodoxime Proxetil IP equivalent to Cefpodoxime 50 mg. 0 Character N N N
A)Assay by weight: Ceftriaxone USP on Anhydrous Basis 0 Character N N N
A)Average net volume 0 Character N N N
A)By Chemical 0 Character N N N
a)NLT 60 % (Q) i.e 65 % of the labeled amount of cefuroxime released in 15 min. 0 Character N N N
A)NLT 90% of L.C the stated amount of Cefixime released in 45 min. 0 Character N N N
A-. Stearic acid 0 Character N N N
A. Benzene 0 Character N N N
A. II –Distinction from locust Bean Gum 0 Character N N N
A. Thiazolylacetyl glycine oxime 0 Character N N N
A.) Glass Grain Test 0 Character N N N
A1) For Tazobactam % Single Maximum unknown impurity: 0 Character N N N
A2) For Tazobactam % Total unknown impurity: 0 Character N N N
Absorbance 0 Character N N N
Acetic Acid 0 Character N N N
Acetone 0 Character N N N
Acetone(%w/w) By GC 0 Character N N N
Acetonitrile 0 Character N N N
Acetyl value 0 Character N N N
Acid value of the fatty acids 0 Character N N N
Acid insoluble substances 0 Character N N N
Acid soluble Substances 0 Character N N N
Acid Value 0 Character N N N
acid1 0 Character N N N
Acidity 0 Character N N N
Acidity or Alkalinity 0 Character N N N
Acidity or Alkalinity (pH ) 0 Character N N N
Acidity or alkalinity (B.)Methyl orange indicator 0 Character N N N
Acidity or alkalinity( A.)BPR indicator 0 Character N N N
Adhesive 0 Character N N N
Adhesive Coating 0 Character N N N
Adhesive Gsm 0 Character N N N
Adhesive layer GSM 0 Character N N N
Adhesive Test 0 Character N N N
Adsorption Capacity 0 Character N N N
Aldehydes 0 Character N N Y
Aldehydes and Ketones 0 Character N N N
Alignment 0 Character N N N
Alkaline impurities 0 Character N N N
Alkalinity 0 Character N N N
All other Impurities 0 Character N N N
Alu foil gsm* 0 Character N N N
Alu foil Thickness 0 Character N N N
Aluminium 0 Character N N N
Aluminium (Chemical Method) 0 Character N N N
Aluminium GSM 0 Character N N N
Aluminium Thickness(mm) 0 Character N N N
Aluminum (as AL) 0 Character N N N
Aluminum, calcium & related elements 0 Character N N N
Ammonia Compounds 0 Character N N N
Ammonium 0 Character N N N
Amoxicillin Related Compound A 0 Character N N N
Anhydrous Di-sodium hydrogen 0 Character N N N
Antimony 0 Character N N N
Any Individual Impurity 0 Character N N N
Any Individual unspecified impurity 0 Character N N N
Any maximum impurity 0 Character N N N
Any other highest unknown impurity 0 Character N N N
Any other Impurity 0 Character N N N
Any Other Individual Impurity 0 Character N N N
any other of fatty acid 0 Character N N N
Any other secondary impurity 0 Character N N N
Any Unspecified degradation product 0 Character N N N
Appearance 0 Character N N N
Appearance After Constitution 0 Character N N N
Appearance of Content 0 Character N N N
Appearance of solution 0 Character N N N
Appearance of solution (A.)Clarity of solution 0 Character N N N
Appearance of solution (B.)Colour of solution 0 Character N N N
Appearance of solution (Clarity and colour of solution) 0 Character N N N
Appearance of solution of the fatty acid 0 Character N N N
Apperance of solution (1.2 % w/v solution in water) 0 Character N N N
AQL 0 Character N N N
Arachidic acid 0 Character N N N
Arsenic 0 Character N N N
Arsenic (as AS ) 0 Character N N N
Arsenic (as As) 0 Character N N N
Arsenic Test(µg) 0 Character N N N
Artwork code 0 Character N N N
Ash 0 Character N N N
Assay 0 Character N N N
Assay Potency (HPLC) withdrawable basis 0 Character N N N N
Assay ( In House ) 0 Character N N N
Assay ( on ignite basis ) 0 Character N N N
Assay (By Potentiometry) 0 Character N N N
Assay (mg per vial) Each vial contains:Cefoperazone Sodium IPEq. to Cefoperazone 0 Character N N N
Assay ( Bacterial count ) 0 Character N N N
Assay ( By GC) 0 Character N N N
Assay ( on anhydrous basis ) 0 Character N N N
Assay (% Lable claim) Each vial containes: Ceftriaxone Sodium IP eq. to Ceftriaxone % 0 Numeric Range N N N
Assay (% w/w) by HPLC (as Tazobactam on anhydrous basis) % 0 Numeric Range N N N
Assay (% w/w) by HPLC (on anhydrous basis and acetone free basis) % 0 Character N N N
Assay (% w/w) by HPLC (on anhydrous basis) 0 Character N N N
Assay (% w/w) by HPLC (on as is basis) 0 Character Y N N
Assay (% w/w) by HPLC* 0 Character N N N
Assay (%w/w, on anhydrous basis, as Enmetazobactam ( By HPLC) 0 Character N N N
Assay (After 7th day) by HPLC Each 5 ml of the reconstituted suspension contains:Cefpodoxime Proxetil IP equivalent toCefpodoxime 100 mg. 0 Character N N N
Assay (By HPLC %(on dried and sodium carbonate-free basis) 0 Character N N N N
Assay (by HPLC µg/mg of Cefpodoxime on anhydrous basis) 0 Character N N N
Assay (By HPLC) 0 Character N N N
Assay (By HPLC) (Cefixime on anhydrous basis) 0 Character N N N
Assay (By HPLC) (on anhydrous basis) 0 Character N N N
Assay (By HPLC) Content of Ceftazidime on as is basis 0 Character N N N N
Assay (By HPLC) On as is basis Avibactam content 0 Character N N N N
Assay (By Ion chromatography) Content of Sodium chloride 0 Character N N N N
Assay (By titration) 0 Character N N N
Assay (By Titrimetry) On dried basis 0 Character N N N
Assay (By Titrimetry)Magnesium(on dried basis) 0 Character N N N
Assay (g/vial)Each vial contains:Ceftriaxone Sodium USP eq. to Ceftriaxone 0 Character N N N
Assay (mg per vial ) Chaque flacon contient:Ceftriaxone Sodium BP Eq. to Ceftriaxone . 0 Character N N N
Assay (mg per vial) Each vial contains: Cefuroxime Sodium IP eq. to Cefuroxime 0 Character N N N
Assay (mg per vial)Each vial contains:Ceftriaxone Sodium BP Equivalent to Ceftriaxone 1 g 0 Character N N N
Assay (mg per vial)Each vial contains:Ceftriaxone Sodium BP Equivalent to Ceftriaxone 500 mg 0 Character N N N
Assay (mg/vial)Each vial contains:Ceftriaxone Sodium IP (Sterile)eq. to Ceftriaxone 250 mg 0 Character N N N
Assay (On Anhydrous basis) 0 Character N N N N
Assay (on anhydrous basis): By potentiometry. 0 Character N N N
Assay (on ignite basis) 0 Character N N N
Assay (on the anhydrous basis) 0 Character N N N
Assay (on the dried basis) 0 Character N N N
Assay : by HPLC Each film coated tablet contains: 0 Character N N N
ASSAY : By Titrimetry 0 Character N N N
Assay By AAS (%w/w) (Content of Galactomannans) 0 Character N N N
Assay By GC 0 Numeric Range N N N
Assay by HPLC 0 Character N N N N
Assay By HPLC (in µg/mg, on anhydrous basis) 0 Character N N N
Assay by HPLC (on dried basis) 0 Character N N N
Assay by tirimetry 0 Character N N N
Assay by Titration ( on dried basis) 0 Character N N N
Assay of Ceftazidime ( By HPLC , on as is basis) 0 Character N N N
Assay of Ciprofloxacin 0 Character N N N
Assay of Dexamethasone 0 Character N N N
ASSAY OF Si02 (%) Calculated on the ignite basis 0 Character N N N
Assay on 14th day of reconstitution 0 Character N N N
Assay on dried basis % w/w 0 Character N N N
Assay pyruvoyl groups ( on dried basis ) 0 Character N N N
Assay(w/w) by HPLC (ceftriaxone on anhydrous basis) 0 Character N N N
Assay: By HPLC 0 Character N N N
Assay: by HPLC Each 5 ml of the reconstituted suspension contains: Cefadroxil IP Equivalent to anhydrous Cefadroxil 125 mg. 0 Character N N N
Assay: by HPLC, Each 5 ml of the reconstituted suspension contains: Cefuroxime Axetil USP equivalent to Cefuroxime 125 mg: 0 Character N N N
Assay: By Titrimetry: 0 Character N N N
Assay: By titrimetry: calculated on the dried basis. 0 Character N N N
Assay: By Ultraviolet and visible absorption spectrophotometry: calculated with reference to the dried substance. 0 Character N N N
Assay: Each vial contains Cefotaxime sodium (sterile) USP eq. to Cefotaxime 1g 0 Character N N N
Assay: Each vial contains Cefotaxime sodium (sterile) USP eq. to Cefotaxime 500 mg 0 Character N N N
Assay: Ratio of Alkyl components. (By: HPLC.) n-C12H25 homolog 0 Character N N N
Assay: Ratio of Alkyl components. Total amounts of the n-C12H25 & n-C14H29 homolog. 0 Character N N N
Assay: Ratio of Alkyl components.n-C12H25 homolog 0 Character N N N
Assay: Ratio of Alkyl components.n-C14H29 homolog 0 Character N N N
Assay: Total alkyl benzyldimethylammonium chlorides. (By: Titrimetry) 0 Character N N N
Assay:(A mixture of Epimers A and B C25H34O6, On dried basis) 0 Character N N N
Assay:. by HPLC Each 5 ml of the reconstituted suspension Cefadroxil IP Equivalent to anhydrous Cefadroxil 250 mg. 0 Character N N N
Average Fill Weight 0 Character N N N
Average filled Volume 0 Character N N N
Average weight 0 Character N N N
Average weight (Only cap) (g) 0 Character N N N
Avg.weight 0 Character N N N
Avibactam content ( By HPLC on as is basis ) 0 Character N N N
Avibactam Sodium Content (By HPLC on as is basis) 0 Character N N N
Azithromycin Impurity (B) 0 Character N N N
Azithromycin IP 250 mg: 0 Character N N N
B) 0 Character N N N
B) Sodium Test 0 Character N N N
B) Assay (After 7th day)by HPLC Each 5 ml reconstituted suspension contains:Cefixime IP (as Trihydrate) equivalent to Anhydrous Cefixime 100 mg. 0 Character N N N
b) 5 ml marking 0 Character N N N
B) Acid value 0 Character N N N
B) Assay (After 7th day) by HPLC 0 Character N N N
B) Assay (After 7th day) Cephalexin IP equivalent to anhydrous Cephalexin 125 mg. 0 Character N N N
B) Assay (After 7th day) Each 5 ml of the reconstituted suspension contains:Cefixime IP as Trihydrate equivalent to anhydrous Cefixime 100 mg. 0 Character N N N
B) Assay (After 7th day): Each 5 ml reconstituted suspension contains: Cefixime Trihydrate IP equivalent to Cefixime anhydrous 40 mg 0 Character N N N
B) Assay (in %) (Each vial contains: Sulbactam Sodium USP eq. to Anhydrous Sulbactam) % 0 Numeric Range N N N
B) Assay (in %) Sulbactam Sodium USP Eq.to Sulbactam (%w/w) 0 Numeric Range N N N
B) Azithromycin 0 Character N N N
B) Azithromycin by HPLC 0 Character N N N
B) By Sodium 0 Character N N N
B) By Acid Value of Fatty Acid 0 Character N N N
B) By Assay Test 0 Character N N N
B) By Chemical 0 Character N N N
B) By Chemical test 1 0 Character N N N
B) By Colour test 0 Character N N N
B) By GC 0 Character N N N
B) By HPLC 0 Character N N N
B) By IR 0 Character N N N
B) By Light obscuration particle count test 0 Character N N N
B) By Light obscuration particle count test 0 Character N N N
B) By Melting point 0 Character N N N
B) By Refractive index 0 Character N N N
B) By TLC 0 Character N N N
B) By UV 0 Character N N N
B) By Viscosity: Degree of polymerization 0 Character N N N
B) Cefoperazone 0 Character N N N N
B) Cefoperazone (activity) 0 Character N N N N
B) Clarity with acetic acid 0 Character N N N
B) Hydroxyl value 0 Character N N N
B) Individual net volume 0 Character N N N
B) Limit of Diethylene glycol and ethylene glycol: 0 Character N N N
B) NLT 70 % (Q) i.e 75 % of the labeled amount of cefuroxime released in 45 min. 0 Character N N N
B) NLT 75% (D) i.e 80 % of the stated amount of Ofloxacin released in 45 min. 0 Character N N N
b) NMT 20.0% particles should retain on #200 mesh ASTM (75µm) 0 Character N N N
B) Ofloxacin released in 45 min. 0 Character N N N
B) Salmonella 0 Character N N N
B) Salmonellae and Shigella 0 Character N N N
B) Sodium salt Test 0 Character N N N
B) Test of sodium 0 Character N N N
B) Total fungal count 0 Character N N N
B) Total molds and yeasts count 0 Character N N N
B)1 For Ofloxacin % Single Maximum Impurity: 0 Character N N N
B)2 For Ofloxacin % Total Impurities: 0 Character N N N
B)Assay (After 7th day of reconstitution) by HPLC Cefixime USP (as Trihydrate) equivalent to Anhydrous Cefixime 50 mg. 0 Character N N N
B)Assay (After 7th day) by HPLC Cefpodoxime Proxetil IP equivalent to Cefpodoxime 50 mg.. 0 Character N N N
B)Assay (After 7th day) by HPLC Each 5 ml reconstituted suspension contains:Cefixime Trihydrate IP equivalent to Cefixime anhydrous 50 mg. 0 Character N N N
B)Assay (After 7th day) by HPLCEach 5 ml reconstituted suspension contains: Cefixime Trihydrate IP equivalent to Cefixime 0 Character N N N
B)Assay (After 7th day) by HPLCEach 5 ml reconstituted suspension contains: Cefixime Trihydrate IP equivalent to Cefixime anhydrous 50 mg. 0 Character N N N
B)Assay (After 7th day) by HPLCEach 5 ml reconstituted suspension contains: Ofloxacin IP 50 mg:. 0 Character N N N
B)By HPLCEach 5 ml of the reconstituted suspension Assay (After 7th day) contains:Cefpodoxime Proxetil IP equivalent to Cefpodoxime 50 mg. 0 Character N N N
b)NLT 75 % (Q) i.e 80 % of the labeled amount of cefuroxime released in 45 min. 0 Character N N N
B)NLT 90% of L.C the stated amount of Ofloxacin released in 45 min. 0 Character N N N
B)Solution A with strong hydrogen peroxide solution produces orange- red colour . 0 Character N N N
B)Specific Microbial Limit (Pathogens) 0 Character N N N
B)Total fungal count 0 Character N N N
B- The sum of stearic acid and palmitic acid 0 Character N N N
B. Total unknown impurities apart from 2-butanol 0 Character N N N
B.Degree of Polymerization 0 Character N N N
B.Thiazolylacetyl glycine oxime acetal 0 Character N N N
B.Total Impurities other than 2-Butanol 0 Character N N N
B1) For Ceftriaxone % Single Maximum unknown impurity: 0 Character N N N
B1) for ≥ 10µ 0 Character N N N
B2) For Ceftriaxone % Total unknown impurity 0 Character N N N
B2) for ≥ 25µ 0 Character N N N
Bacterial Endotoxin 0 Character N Y N
Bacterial Endotoxin (Endotoxin Unit per mg for both ) 0 Character N Y N
Bacterial Endotoxin Test 0 Character N N N
Bacterial Endotoxin test: 0 Character N N N
Barcode 0 Character N N N
Barium 0 Character N N N
Base colour 0 Character N N N
Base Outer Diameter 0 Character N N N
Benzene 0 Character N N N
Benzene and related substances by GC 0 Character N N N
Benzoate 0 Character N N N
Benzoic Acid 0 Character N N N
Bile tolerant gram-negative Bacteria 0 Character N N N
Bled Uniformity. 0 Character N N N N
Bleeding 0 Character N N N
Board Grammage 0 Character N N N
Board quality 0 Character N N N
Body Outer Diameter (mm) 0 Character N N N
Boiling Range 0 Character N N N
Bottom Layer 0 Character N N N
Bottom Outer Dia (mm) 0 Character N N N
Braille Test 0 Character N N N
Bromide 0 Character N N N
Bromide and Iodide 0 Character N N N
Bromide: By Visible absorption spectroscopy 0 Character N N N
Bromoacetyl analog 0 Character N N N
BUDATE BACK LABEL TRANSPULE 0 Character N N N
BUDATE BACK LABLE TRANSPULE 0 Character N N N
BUDATE BACK LABLE TRANSPULE 271771 0 Character N N N
Budate Carrugated Box 525x340x305 mm 0 Character N N N
BUDATE CARTON 0 Character N N N
BUDATE FRONT LABEL 0 Character N N N
BUDATE POUCH LABEL 0 Character N N N
BUDATE TRANSPULE PRINTED INSERT 0 Character N N N
BUDECORT RESPULES 0.5 MG POUCH LABEL 0 Character N N N
Buffering Capacity 0 Character N N N
Buffering capacity 0 Character N N N
Bulk Density 0 Character N N N
Bulk Density 0 Character N N N
Burst factor 0 Character N N N
Burst strength 0 Character N N N
Bursting Strength (kg/cm2) 0 Character N N N
By HPLC 0 Character N N N
By IR 0 Character N N N
C) 0 Character N N N
c) 10 ml marking 0 Character N N N
C) Absorbance at 430nm (10 % w/v solution in water) 0 Character N N N
C) By Chemical 0 Character N N N
C) By Chemical test 0 Character N N N
C) By chemical test 2 0 Character N N N
C) By GC 0 Character N N N
C) By HPLC 0 Character N N N
C) By IR# 0 Character N N N
C) By Sodium test 0 Character N N N
C) By TLC 0 Character N N N
C) By UV 0 Character N N N
C) Escherichia coli 0 Character N N N
C) Pathogen count 0 Character N N N
C) Pseudomonas aeruginosa 0 Character N N N
C) Test of sodium 0 Character N N N
C)Escherichia coli 0 Character N N N
C)Solution A with zinc granules produces a violet blue colour. 0 Character N N N
C. Cefdinir Sulfoxide 0 Character N N N
Cadmium ( as Cd ) 0 Character N N N
Cadmium (as Cd) 0 Character N N N
calcium 0 Character N N N
Calcium and Magnesium 0 Character N N N
Calcium and magnesium ( Calculated as Ca) 0 Character N N N
Calcium and magnesium: 0 Character N N N
Caliper 0 Character N N N
Caliper(thickness) 0 Character N N N
Cap Fitment & Sealing 0 Character N N N
Cap Height 0 Character N N N
Cap ID 0 Character N N N
Cap OD 0 Character N N N
Cap weight 0 Character N N N
Caproic acid: 0 Character N N N N
Caprric acid: 0 Character N N N N
Caprylic acid: 0 Character N N N N
Carbonates 0 Character N N N
Cefadroxil Impurity-A 0 Character N N N
Cefadroxil Impurity-B 0 Character N N N
Cefadroxil IP Equivalent to anhydrous Cefadroxil 250 mg 0 Character N N N
Cefadroxil IP equivalent to Anhydrous Cefadroxil 500 mg 0 Character N N N
Cefadroxil IP equivalent to Anhydrous Cefadroxil125 mg. 0 Character N N N
Cefdinir USP equivalent to anhydrous Cefdinir 300 mg. 0 Character N N N
cefepime 0 Character N N N
Cefepime Hydrochloride IP eq. to Cefepime % 0 Numeric Range N N N
Cefepime Impurity (A) 0 Character N N N
Cefepime Impurity (B) 0 Character N N N
Cefepime Related Compound A 0 Character N N N
Cefepime Related Compound C 0 Character N N N
Cefetamet 0 Character N N N
Cefixime 200 mg:Ofloxacin IP 200 mg: 0 Character N N N
Cefixime Trihydrate IP equivalent to anhydrous 0 Character N N N
Cefixime Trihydrate IP equivalent to anhydrous Cefixime 100 mg.. 0 Character N N N
Cefixime Trihydrate IP equivalent to anhydrous Cefixime 200 mg. 0 Character N N N
Cefixime Trihydrate IP equivalent to Cefixime 0 Character N N N
Cefixime Trihydrate IP equivalent to Cefixime (Anhydrous) 50 mg. 0 Character N N N
Cefixime Trihydrate IP equivalent to Cefixime anhydrous 50 mg. 0 Character N N N
Cefixime Trihydrate USP equivalent to anhydrous Cefixime 200 mg. 0 Character N N N
Cefixime Trihydrate USP equivalent to Cefixime (Anhydrous) 100 mg. 0 Character N N N
Cefixime USP (as Trihydrate) equivalent to Anhydrous Cefixime 100 mg. 0 Character N N N
Cefixime USP (as Trihydrate) equivalent to Anhydrous Cefixime 50 mg 0 Character N N N
Cefoperazone 0 Character N N N N
Cefoperazone Sodium IP Eq. to Cefoperazone 0 Character N N N
Cefoperazone Sodium USP Eq. to Cefoperazone 0 Character N N N
Cefotaxime dimer 0 Character N N N
Cefotaxime open ring lactone 0 Character N N N
Cefotaxime related compound E 0 Character N N N
Cefotaxime sodium (sterile) USPeq. to Cefotaxime 500 mg 0 Character N N N
Cefotaxime Sodium equivalent to Cefotaxime in (%) Labeled Amount 0 Character N N N
Cefpodoxime Proxetil IP equivalent to Cefpodoxime 100 mg. 0 Character N N N
Cefpodoxime Proxetil IP equivalent to Cefpodoxime 100 mg. 0 Character N N N
Cefpodoxime Proxetil IP equivalent to Cefpodoxime 200 mg. 0 Character N N N
Cefpodoxime Proxetil IP equivalent to Cefpodoxime 50 mg.. 0 Character N N N
Ceftazidime pentahydrate equivalent to Ceftazidime (C22H22N6O7S2) In (%) Labeled Amount 0 Character N N N
Ceftriaxone -3-ene isomer 0 Character N N N
Ceftriaxone benzothiazolyoxime 0 Character N N N
Ceftriaxone E-Isomer 0 Character N N N
Ceftriaxone Sodique BP (Sterile) Equivalent to Ceftriaxone 1000 mg 0 Character N N N
Ceftriaxone Sodium IP (Sterile) eq. to Anhydrous Ceftriaxone 0 Character N N N
Ceftriaxone Sodium IP eq. to anhydrous Ceftriaxone 0 Character N N N
Ceftriaxone Sodium IP Eq. to Ceftriaxone 0 Character N N N
Ceftriaxone Sodium USP eq. to Ceftriaxone 0 Character N N N
Ceftriaxone triazine analog 0 Character N N N
Ceftriaxone USP On Anhydrous Basis 0 Character N N N
Cefuroxime 0 Character N N N
Cefuroxime axetil dimer 0 Character N N N
Cefuroxime Axetil D³-isomers 0 Character N N N
Cefuroxime Axetil E-isomers 0 Character N N N
Cefuroxime Axetil equivalent to Cefuroxime (C16H16N4O8S), in mg (%) Labeled amount 0 Character N N N
Cefuroxime Axetil IP equivalent to 0 Character N N N
Cefuroxime Axetil IP equivalent to Cefuroxime 250 mg. 0 Character N N N
Cefuroxime Axetil IP equivalent to Cefuroxime 500 mg. 0 Character N N N
Cefuroxime Axetil USP equivalent to 0 Character N N N
Cefuroxime Axetil USP equivalent to Cefuroxime 125 mg. 0 Character N N N
Cefuroxime Axetil USP equivalent to Cefuroxime 500 mg. 0 Character N N N
Cefuroxime lactone 0 Character N N N
Chloride 0 Character N N N
Chlorides 0 Character N N N
Chlorinated Compounds 0 Character N N N
Chromatographic Purity 0 Character N N N
Chromatographic Purity (%) (By HPLC) 0 Character N N N
Chromatographic purity* (By HPLC) 0 Character N N N
Cinnamic Acid 0 Character N N N
CIPLOX-D EYE/EAR DROP CARTON 10 ML 0 Character N N N
CIPLOX-D EYE/EAR DROPS 10 ML LABELS 0 Character N N N
Claim 0 Character N N N
Clarity of Solution 0 Character N N N
Cleanliness 0 Character N N N
Code no is missing 0 Character N N N
Code No. is missing or is not in accordance with the standard 0 Character N N N
Color (425nm,cmcell) 6.2ml WFI/vial 0 Character N N N N
Color index (10% solution w/v ) 0 Character N N N N
Color of Reconstituted Solution 0 Character N N N
color of solution 0 Character N N N
colorant 0 Character N N N
Colour 0 Character N N N
Colour Absorbance 0 Character N N N
Colour Index Absorbance of a 5% w/v solution of sample at 240nm is not more than 0.060. 0 Character N N N
Colour Index (5g in 50 ml) 0 Character N N N
Colour Lake Sun Yellow 0 Character N N N
Colour lifting 0 Character N N N
Colour Of Flip Off Disc 0 Character N N N
Colour of solution (By UV) 0 Character N N N
Colour scheme 0 Character N N N
Colour Shade 0 Character N N N
colour shade of kraft paper 0 Character N N N
Colour Value 0 Character N N N
Colouring matter 0 Character N N N
Combined Ether Extracts 0 Character N N N
Compound A (Aminosulfinic acid) 0 Character N N N
Compound A (Aminosulfinic acid)Individual Impurity 0 Character N N N
Compressibility index 0 Character N N N
Compression strength 0 Character N N N
Condition of Core 0 Character N N N
Condition of Roll 0 Character N N N
Conductivity 0 Character N N N
Congealing Temperature 0 Character N N N
Constituted solution 0 Character N N N
Constituted solution (Clarity of solution ) 0 Character N N N
Constituted solution (Completeness & Clarity of Solution ) 0 Character N N N
Constituted Solution, Completeness and clarity of solution (1g in 10 ml ) 0 Character N N N
Content of 2,3, cyclopentane 5 pyridine 0 Character N N N
Content of Water soluble material 0 Character N N N
Content of Arginine 0 Character N N N
Content of Avibactam sodium equivalent to Avibactam 0 Character N N N
Content of Cefepime 0 Character N N N
Content of Ceftazidime on as is basis 0 Character N N N
Content of ceftazidime pentahydrate equivalent to ceftazidime 0 Character N N N
Content of Glycopyrrolate equivalent to Glycopyrronium 0 Character N N N N
Core Diameter (mm) 0 Character N N N N
Core used 0 Character N N N
Creasing Quality 0 Character N N N
Crystallinity 0 Character N N N
Cutting and Creasing 0 Character N N N
Cyclohexane 0 Character N N N
D) 0 Character N N N
D) By Chemical 0 Character N N N
D) Chemical test 0 Character N N N
D) Salmonella 0 Character N N N
D) Staphylococcus aureus 0 Character N N N
D) TLC 0 Character N N N
D)By Melting point 0 Character N N N
D)Salmonella spp. 0 Character N N N
D-Phenylglycine 0 Character N N N
D. Cefdinir thiazine analog 0 Character N N N
D10 0 Character N N N
D3- isomers 0 Character N N N
d50 0 Character N N N
d90 0 Character N N N
d97 0 Character N N N
Deacetylcefotaxime lactone 0 Character N N N
Deacyl Ceftriaxone 0 Character N N N
Degree of Polymerization 0 Character N N N
Degree of substitution (on dried basis) 0 Character N N N
Deliverable volume 0 Character N N N
Descarbamoyl – cefuroxime Impurity 0 Character N N N
Descorbomoyl Cefuroxime Impurity 0 Character N N N
Description A clear or almost clear, Oily, yellowish or brownish yellow liquid, Odour faint and Charateristic. 0 Character N N Y
Design 0 Character N N N
Dexamethasone content 0 Character N N N
Dextrins 0 Character N N N
Diameter (in mm) 0 Character N N N
Diameter Of Flip- Off Disc 0 Character N N N
Diameter Of Wad(mm) 0 Character N N N
Diastereoisomer ratio 0 Character N N N
Dichloromethane 0 Character N N N
Didehydroglycopyrrolate 0 Character N N N N
Differential scanning calorimetry 0 Character N N N
Diglyme ether 0 Character N N N N
Dimethyl Formamide 0 Character N N N N
Disintegration Test 0 Character N N N
Dispersion Time 0 Character N N N
Dissolution (% Drug Release) 0 Character N N N
Dissolution By UV 0 Character N N N
Distillation Range 0 Character N N N
Dodecane 0 Character N N N N
Dye Content 0 Character N N N
E coli 0 Character N N N
E) 0 Character N N N
E) By chemical 0 Character N N N
E) Pseudomonas Aeruginosa 0 Character N N N
E)Pseudomonas Aeruginosa 0 Character N N N
E- isomers 0 Character N N N
E-Cefotaxime 0 Character N N N
E. Cefdinir impurity 1 0 Character N N N
E. coli 0 Character N N N
Each 5 ml of the reconstituted suspension contains:Cephalexin IP equivalent toanhydrous Cephalexin 125 mg. 0 Character N N N
Each film coated tablet contains: Cefuroxime Axetil USP equivalent to Cefuroxime 250 mg 0 Character N N N
Each film coated tablet contains:Cefpodoxime Proxetil IP equivalent to Cefpodoxime200 mg. 0 Character N N N
Each Hard gelatin capsule contains: Amoxycillin Trihydrate IP eq. to amoxycillin 0 Character N N N N
Each tablet contains: Cephalexin equivalent to Anhydrous Cephalexin 250 mg. % 0 Numeric Range N N N N
Each tablet contains:Cephalexin equivalent to Anhydrous Cephalexin 125 mg. 0 Character N N N
Each vial contains Cefazolin sodium equivalent to Cefazolin in mg In (%) Labeled Amount 0 Character N N N
Each vial contains Cefuroxime Sodium equivalent to Cefuroxime (C16H16N4O8S), in mg 0 Character N N N
Each vial contains: Ceftriaxone Sodium IP Eq. to Ceftriaxone % 0 Numeric Range N N N
Each vial contains: Ceftriaxone Sodium USP eq. to Ceftriaxone 0 Character N N N
Each vial contains:Cefotaxime Sodium IP eq. to Cefotaxime 0 Character N N N
Each vial contains:Cefotaxime sodium USP eq. to cefotaxime 0 Character N N N
Each vial contains:Cefuroxime Sodium IP eq. to Cefuroxime % 0 Numeric Range N N N
Elasticity Identification 0 Character N N N
Enantiomeric Purity: By HPLC (S)- Salbutamol Sulphate 0 Character N N N N
Enmetazobactam 0 Character N N N
Enterobacteriaceae Should be absent 0 Character N Y N
Epimer A: By HPLC Not Less Than 40.0 and Not More Than51.0 0 Character N N N
Escherichia coli 0 Character N N N
Ethanol 0 Character N N N
Ethanol by GC 0 Character N N N
Ether -Soluble Substances 0 Character N N N
Ether Extractable matter 0 Character N N N
Ethyl Acetate 0 Character N N N
Ethylene dichloride 0 Character N N N N
Ethylene glycol & diethylene glycols( by GC ) 0 Character N N N
Extractable Heavy metals Extractable Heavy metals 0 Character N N N
Extractable Volume 0 Character N N N
Extractable ZINC 0 Character N N N
F) Staphylococcus 0 Character N N N
F)Staphylococcus aureus 0 Character N N N
F. 3-Methyl Cefdinir 0 Character N N N
Face Paper 0 Character N N N
Face stock 0 Character N N N N
Fatty acid composition ( by GC ) 0 Character N N N
Ferrocyanide 0 Character N N N
Fill weight 0 Character N N N N
Fill weight (Average) (20 vials) (Individual) 0 Character N N N N
Fill weight (Average) (20 vial) 0 Character N N N N
Fill weight (Average) (20 vials) (Individual) 0 Character N N N N
First substrate (PET) GSM 0 Character N N N
Fitting 0 Character N N N
Fitting of screw cap with bottle 0 Character N N N
Flange Thickness (Collar) Flange Thickness (Collar) 0 Character N N N
Flavour / odor 0 Character N N N
Flavour Strength 0 Character N N N
Flavour/Odor 0 Character N N N
Fluorences 0 Character N N N
Fluorescent Impurity 0 Character N N N
Fluoroquinolonic acid: (By TLC) 0 Character N N N
Flute 0 Character N N N
Flute 1 0 Character N N N
Flute 3 0 Character N N N
flute2 0 Character N N N
Fluticasone acetate 0 Character N N N N
Fluticasone acid 0 Character N N N N
Fluticasone acid Propionate 0 Character N N N N
Foil thickness (mm) 0 Character N N N
Folding 0 Character N N N
Folding Quality 0 Character N N N
Folding Size (Width mm) 0 Character N N N
Folding Size (Length mm) 0 Character N N N
for ≥ 10µ 0 Character N N N
for ≥ 25µ 0 Character N N N
For , nominal volume of more than 5 ml 0 Character N N N
for > 10 ml volume 0 Character N N N
For Arginine 0 Character N N N
For Avibactam 0 Character N N N
For Cefepime 0 Character N N N
For CEFIXIME 0 Character N N N
For Ceftazidime 0 Character N N N
For Glycopyrronium < By HPLC> 0 Character N N N N
For Ofloxacin 0 Character N N N
for ¡Ü 10 ml volume 0 Character N N N
For, nominal volume of 5 ml or less than 5 ml 0 Character N N N
Foreign Amines 0 Character N N N
Foreign matter 0 Character N N N
Foreign matter(6.2 ml of WFI/vial) 0 Character N N N N
Formic acid 0 Character N N N
Fourth substrate (Poly) GSM 0 Character N N N
Fragmentation Test 0 Character N N N
Free Chlorine 0 Character N N N
Free Dye Content 0 Character N N N
Free fatty acids 0 Character N N N
Free stearic acid 0 Character N N N
Freezing point 0 Character N N N
Friability 0 Character N N N
Fumaric Acid Content: (By HPLC) 0 Character N N N N
fungus(cfu/g) Not more than 100 0 Character N Y N
G. Cefdinir Related compound A 0 Character N N N
Gap between labels 0 Character N N N
Glass Grains Test(ml) 0 Character N N N
Glucose and invert sugar 0 Character N N N
Glycopyrrolate Related Compound B 0 Character N N N
Glycopyrrolate Related Compound C 0 Character N N N
Glycopyrrolate Related compound I 0 Character N N N
Glycopyrrolate Related Compound L 0 Character N N N
Grade 0 Character N N N N
Grain Direction 0 Character N N N
Gramage Of Aluminium Foil Without VMCH/HSL/Universal HSL 0 Character N N N
GramageOf VMCH/HSL/Universal HSL Coating 0 Character N N N
Grammage (gsm) 0 Character N N N
Grammage Of Polythene 0 Character N N N
Grammage Of Aluminium Foil Without Polythene 0 Character N N N
Grammage of Bottom Layer 0 Character N N N
Grammage of each ply 0 Character N N N
Grammage of each ply Layer-2:- NLT 126 GSM 0 Character N N N
Grammage of each ply Layer-3:- NLT 126 GSM 0 Character N N N
Grammage of each ply Layer-4:- NLT 126 GSM 0 Character N N N
Grammage of each ply Layer-5:- NLT 126 GSM 0 Character N N N
Grammage of Layer-2 0 Character N N N
Grammage of Layer-3 0 Character N N N
Grammage of Layer-4 0 Character N N N
Grammage of Layer-5 0 Character N N N
Grammage of Middle Layer 0 Character N N N
Grammage of Top Layer 0 Character N N N
Grammage of Top Ply 0 Character N N N
GSM 0 Character N N N
GSM Adhesive 0 Character N N N
GSM Adhesive Paper 0 Character N N N
GSM Face Paper : 0 Character N N N
GSM Release Paper 0 Character N N N
GSM (gm/sq. meter) 0 Character N N N
GSM of face stock 0 Character N N N
GSM Of Paper (G/m2) 0 Character N N N N
GSM of PVDC Coating 0 Character N N N
Guage of aluminium 0 Character N N N
GUM 0 Character N N N N
H.Cefdinir Related compound A 0 Character N N N
Halogenated compounds 0 Character N N N
Hardness 0 Character N N N
Hausner ratio 0 Character N N N
Heat seal lacquer 0 Character N N N
Heat seal lacquer coating part 0 Character N N N
Heavy metals 0 Character N N N
Height 0 Character N N N
Height (mm) 0 Character N N N
Height of Partition 0 Character N N N
Height of plastic Disc (mm) 0 Character N N N
Height of Seal Aluminium portion (mm) 0 Character N N N
Hexane (ppm) 0 Character N N N
Highest Individual Impurity 0 Character N N N
HSL coating grammage 0 Character N N N
HSL GSM 0 Character N N N
HYDRAZINE 0 Character N N N
Hydrolytic Resistance (ml) 0 Character N N N
Hydroxyl value 0 Character N N N
Hydroxypropoxy 0 Character N N N
Hydroxypropyl Group 0 Character N N N
i) Ethylene Glycol 0 Character N N N N
i) Escherichia coli 0 Character N N N
i) Ethylene Glycol 0 Character N N N
i)Methonol 0 Character N N N
i)Total aerobic microbial count 0 Character N N N
I. Cefdinir Related compound A 0 Character N N N
ID of Mouth 0 Character N N N
Identification A blue colour is produce on treatment of the sample with chloroform, Potassium thiocyanate and Cobal 0 Character N N N
Identification B : By Thin layer chromatography 0 Character N N N
Identification C The sample solution decolourises bromine water. 0 Character N N N
Identification C : By HPLC 0 Character N N N
Identification (By : IR ) 0 Character N N N
Identification (By Ferric Oxide Test) 0 Character N N N
Identification (By HPLC) 0 Character N N N
Identification (By TLC) 0 Character N N N
IDENTIFICATION A 0 Character N N N
Identification A 0 Character N N N
Identification A For Sodium 0 Character N N N N
Identification B 0 Character N N N
Identification B (By HPLC) 0 Character N N N
Identification B For Chloride 0 Character N N N N
Identification B: (By TLC) 0 Character N N N
Identification By GC 0 Character N N N
Identification By uv 0 Character N N N
Identification C 0 Character N N N
Identification D The Infrared absorption spectrum of sample is concordant with the infrared absorption spectrum of Po 0 Character N N N
Identification for aluminium 0 Character N N N
Identification of Nitrocellulose Coating 0 Character N N N
Identification of PE ( sealant layer ) by IR 0 Character N N N
Identification: (By UV) 0 Character N N N
ii) Diethylene Glycol 0 Character N N N N
ii) Diethylene Glycol 0 Character N N N
ii) P.aeruginosa 0 Character N N N
ii)Ethanol 0 Character N N N
ii)Total molds and yeasts count 0 Character N N N
iii) Triethyene Glycol 0 Character N N N N
iii) S.aureus 0 Character N N N
iii) Triethylene Glycol 0 Character N N N
iii)Acetone 0 Character N N N
IMPURITY -A By -HPLC 0 Character N N N
Impurity A 0 Character N N N
Impurity A (BY TLC) 0 Character N N N N
Impurity B 0 Character N N N
Impurity C 0 Character N N N
Impurity D 0 Character N N N
Impurity E 0 Character N N N
Impurity F 0 Character N N N
Impurity G 0 Character N N N N
Impurity H 0 Character N N N N
Impurity I 0 Character N N N N
Inadequate space for batch details 0 Character N N N
Individual (GSM) 0 Character N N N
Individual (GSM)* 0 Character N N N
Individual Impurity 0 Character N N N
Induction Wad Thickness 0 Character N N N
Initia pH: 0 Character N N N
Ink Details 0 Character N N N
Ink Grade 0 Character N N N
Ink lifting test 0 Character N N N
Ink Shade 0 Character N N N
Inner flap Height(mm) 0 Character N N N
Inner core diameter 0 Character N N N
Inner diameter 0 Character N N N
Inner Diameter of Aluminium Seal (mm) 0 Character N N N
Inner Height of Aluminium seal 0 Character N N N
Inorganic Phosphate : By ultraviolet and visible absorption spectrophotometry Calculated as Po4 0 Character N N N
Inside Height (mm) 0 Character N N N
Insoluble in HCl 0 Character N N N
Insoluble substances 0 Character N N N
Internal Dia (mm) 0 Character N N N
Internal Diameter (mm) 0 Character N N N
Internal Mouth Diameter 0 Character N N N
Internal Mouth Diameter(mm) 0 Character N N N
Iodide 0 Character N N N
Iodides 0 Character N N N N
Iodine value 0 Character N N N
Iron 0 Character N N N
Iron Test 0 Character N N N
Iso-propanol 0 Character N N N
Isomer Ratio (By HPLC) 0 Character N N N
Isopropyl Alcohol 0 Character N N N
iv) Salmonella 0 Character N N N
iv)Isopropyl Alcohol 0 Character N N N
J. Cefdinir Related compound A 0 Character N N N
K-value 0 Character N N N
K. 7-s Cefdinir 0 Character N N N
L. Cefdinir Lactone 0 Character N N N
Label grade 0 Character N N N N
Label manufacturer 0 Character N N N N
LABEL TAMPER EVIDENT FOR MID-MIDAS 0 Character N N N
Labels with missing print 0 Character N N N
Lactic Acid Bacillus 60 million Spores 0 Character N N N
Lactic acid producing capacity 0 Character N N N
Laminated ALU Foil 0 Character N N N
Lauric acid: 0 Character N N N N
LDPE film Grammage 0 Character N N N
Lead 0 Character N N N
Lead (as Pb ) 0 Character N N N
Lead (as Pb) 0 Character N N N
Lead and Heavy Metals 0 Character N N N
Leak Test 0 Character N N N
Length 0 Character N N N
Length (mm) 0 Character N N N
Length After Folding 0 Character N N N
Length of Partition 0 Character N N N
Less than 10 ml volume 0 Character N N N
Levosalbutamol Assay Duolin 0 Character N N N N
Light Absorption 0 Character N N N
Light absorption (Solution A) 0 Character N N N
Light Absorption (by UV) at 440 nm 0 Character N N N
Light absorption : by ultraviolet and visible absorption spectrophotometry 0 Character N N N
Limit (In % w/w) 0 Character N N N
Limit of , Benzaldehyde 0 Character N N N
Limit of Aluminum %w/w 0 Character N N N
Limit of amines and amine salts (By: potentiometry) 0 Character N N N
Limit of Benzyl Alcohol (By: HPLC) 0 Character N N N
Limit of bromides 0 Character N N N N
Limit of Cadmium (ppm) 0 Character N N N
Limit of Calcium %w/w 0 Character N N N
Limit of Chloromethyl benzene : 0 Character N N N
Limit of Erythro Isomer; (By HPLC) 0 Character N N N
Limit of Hydrogen chloride 0 Character N N N
Limit of Iron %w/w * 0 Character N N N
Limit of Lead ppm 0 Character N N N
Limit of Methacrylic Acid and Ethyl Acrylate 0 Character N N N
Limit of N – Methyl pyrrolidine (%w/w) 0 Character N N N
Limit of Nickel (ppm) 0 Character N N N
Limit of nitrilotriacetic acid 0 Character N N N N
Limit of Nonvolatile Residue 0 Character N N N
Limit of oxalic acid 0 Character N N N N
Limit of phosphates 0 Character N N N N
Limit of Pyridine % (w/w) * 0 Character N N N
Liner GSM 0 Character N N N
Liner GSM 0 Character N N N
Linoleic acid 0 Character N N N N
Linoleic acid: 0 Character N N N N
Linolenic acid 0 Character N N N N
Lip Thickness (mm) 0 Character N N N
Lock Property 0 Character N N N
Locking 0 Character N N N
Locking Quality 0 Character N N N
LOD ( for 1 hr at 105 ° C ) 0 Character N N N
LOD(%w/w) %w/w 0 Character N N N
Loss on Attrition 0 Character N N N
Loss on drying at 110ºC 0 Character N N N
Loss on Drying (% w/w) (Use 1.0 g sample dry at 105ºC for 3 hours.) 0 Character N N N
Loss on Drying (% w/w) (Use 1g sample dry at 100¢ªC to 105¨¬C for 3 hours.). 0 Character N N N
Loss on Drying (% w/w)(Use 1g sample dry at 100¢ªC to 105¨¬C for 3 hours.). 0 Character N N N
Loss on Drying (%w/w) 0 Character N N N
Loss On Ignition 0 Character N N N
M. Cefdinir Related compound B 0 Character N N N
Magnesium 0 Character N N N
Magnesium and alkaline-earth metals 0 Character N N N N
Manufacturing Joints 0 Character N N N
Marking of 2.5ml,5ml&10ml 0 Character N N N
Material 0 Character N N N
Material Of Flip off Disc 0 Character N N N
MBT Content ( By HPLC, ppm) 0 Character N N N
medium micro 0 Character N N N
Melt flow index 0 Character N N N
Melting Point 0 Character N N N
Melting range 0 Character N N N
Mercury 0 Character N N N
Mercury ( as Hg ) 0 Character N N N
Mercury (as Hg) 0 Character N N N
Methanol 0 Character N N N
Method-IITriethylamine Content 0 Character N N N
Methoxy 0 Character N N N
Methoxyiminofuranyl acetic acid 0 Character N N N
Methyl Bromide Content: (By GC) 0 Character N N N
Methyl Isobutyl Ketone 0 Character N N N
Methylene Chloride 0 Character N N N
Methylene Dichloride 0 Character N N N
Micro Text embossing 0 Character N N N
Microbial Contamination 0 Character N N N
Microbial Enumeration test 0 Character N N N
Microbial Enumeration test (bioburden) 0 Character N N N
Microbial enumeration tests 0 Character N N N
Microbial test 0 Character N N N
Microbial test A)Total viable count ( 1) Total Aerobic Microbial count 0 Character N N N
Microbial test A)Total viable count ( 2)Total Combined Yeast and Mould count 0 Character N N N
Microbial test B) Test for specified microorganism(2) E.coli 0 Character N N N
Microbial test B)Test for specified microorganism (1) Bile tolerant gram- negative bacteria 0 Character N N N
Microbial test B)Test for specified microorganism (3) Salmonella 0 Character N N N
Microbial test B)Test for specified microorganism(4)Pseudomonas aeruginosa 0 Character N N N
Microbial test B)Test for specified microorganism(5)Staphylococcus aureus 0 Character N N N
Microbial test B)Test for specified microorganism(6)Candida albicans 0 Character N N N
Microbial Tests 0 Character N N N
Microbiological examination of non-sterile products: Aerobic Microbial count: 0 Character N N N
Microbiological examination of non-sterile products: Combined Yeasts and Molds count: 0 Character N N N
Microbiological examination of non-sterile products: Total aerobic microbial count. 0 Character N N N
Microbiological examination of non-sterile products: Total combined Yeast and Molds count. 0 Character N N N
Middle Layer 0 Character N N N
Middle Layer-1 0 Character N N N
Middle Layer-2 0 Character N N N
Middle Layer-3 0 Character N N N
Middle layer-4 0 Character N N N
Middle Layer-5 0 Character N N N
Mineral acid 0 Character N N N
Mix up of other product 0 Character N N N
Mix up of other product Cartons 0 Character N N N
Mix up of other product Labels 0 Character N N N
Moisture % 0 Character N N N
Molar Substitution 0 Character N N N
Monocalcium & Tricalcium Phosphates 0 Character N N N
Monosodium phosphate 0 Character N N N
Morphline Test 0 Character N N N
Mouth Inner Diameter (mm) 0 Character N N N
Mouth Outer Diameter (mm) 0 Character N N N
Myristic acid: 0 Character N N N N
N,N-Dimethylacetanide 0 Character N N N
N,N-Dimethylaniline (ppm) 0 Character N N N
n-Butyl acetate 0 Character N N N
n-Decane 0 Character N N N N
N-Hexane 0 Character N N N N
N.Cefdinir isoxazole analog 0 Character N N N
Name of board 0 Character N N N N
Neck Diameter over collar(mm) 0 Character N N N
Neck Diameter over thread(mm) 0 Character N N N
Neck Height (mm) 0 Character N N N
Neck Inner Diameter (mm) 0 Character N N N
Neck Outer Diameter (mm) 0 Character N N N
Neck Ring OD 0 Character N N N
Neck thread OD 0 Character N N N
Neotame Impurity A 0 Character N N N
Net Content 0 Character N N N N
Nickel 0 Character N N N
Nitrate 0 Character N N N
Nitrites 0 Character N N N N
Nitrogen (Method C) 0 Character N N N
Nitrogen (Method II ) 0 Character N N N
Nitrogen (on anhydrous basis) 0 Character N N N
NLT 75% (D) i.e 80 % of the stated amount of Azithromycin released in 45 min. 0 Character N N N
NLT 90% of the stated amount of Cefixime released in 45 min. 0 Character N N N
No of colour 0 Character N N N
No of contener 0 Character N N N
No. of Net 0 Character N N N
No. of corrugated plates 0 Character N N N
No. of cut lock 0 Character N N N
No. of Piles 0 Character N N N
No. of ply (No’s) 0 Character N N N
No. of Slots 0 Character N N N
No. of Track 0 Character N N N
Non volatile Matter 0 Character N N N
Non volatile residue 0 Character N N N
Non-esterified alcohols 0 Character N N N
Not less than 50% (Q) of label claim shall dissolve in 15 min. 0 Character N N N
Not less than 60% (Q) of label claim shall dissolve in 15 min. 0 Character N N N
Not less than 70% (Q) of label claim shall dissolve in 45 min. 0 Character N N N
Not less than 70% (Q) of label claim shall dissolve in 45 min.. 0 Character N N N
Number Of Bridges 0 Character N N N
Number of joints in a roll 0 Character N N N
Number of Joints per Roll 0 Character N N N
o-toluene sulphonamide 0 Character N N N
O. Cefdinir impurity 2 0 Character N N N
OBERVATION 0 Character N N N
OD of Mouth 0 Character N N N
Odour 0 Character N N N
OFLOX-D EYE/EAR DROPS 10 ML LABELS 0 Character N N N
Ofloxacin IP 200 mg 0 Character N N N
Ofloxacin IP 50 mg: 0 Character N N N
Oil Content 0 Character N N N
Oleic acid: 0 Character N N N N
Opening Test 0 Character N N N
optical rotation 0 Character N N N
Organic Colors & Lakes 0 Character N N N
Organic Compounds 0 Character N N N
Organic Impurities 0 Character N N N
Organic Impurities Limit of N–Methyl pyrrolidine (%w/w) 0 Character N N N
Osmolality 0 Character N N N
other polysaccharides 0 Character N N N
Other related substances Total Impurities (excluding 5- Benzyl-3,6-dioxo-2-piperazineacetic acid) 0 Character N N N
Outer flap Height(mm) 0 Character N N N
Outer Dia (mm) 0 Character N N N
Outer Dia Bottom (mm) 0 Character N N N
Outer Diameter (mm) 0 Character N N N
Outer diameter at base 0 Character N N N
Outer Diameter of Aluminium seal (mm) 0 Character N N N
Outer Diameter of flip off seal (mm) 0 Character N N N
Outer Diameter Plastic Portion (mm) 0 Character N N N
Outer Roll Diameter 0 Character N N N
Over flow Capacity (ml) 0 Character N N N
Overall Height 8.00 mm to 8.80 mm 0 Character N N N
Oxalate 0 Character N N N
Oxalic acid 0 Character N N N
Oxidation of Roll 0 Character N N N
Oxidising Substances 0 Character N N N
Oxidizable substances 0 Character N N N
p- toluene sulphonamide 0 Character N N N
p-Hydroxybenzoic acid 0 Character N N N
P. Cefdinir glyoxalic analog 0 Character N N N
P.aeruginosa 0 Character N N N
Packing 0 Character N N N
Palmitic acid 0 Character N N N
Palmitic acid: 0 Character N N N N
Palmitoleic acid 0 Character N N N N
PANTONE 0 Character N N N
Paper 0 Character N N N
Paper Grammage 0 Character N N N
Paper Gsm 0 Character N N N N
Paper Substrate Grade 0 Character N N N
Paper with Adhesive 0 Character N N N
Partical size : X10 Not more than1.0 0 Character N N N
Partical size:X50 Not more than3.0 0 Character N N N
Partical size:X90 Not more than5.0 0 Character N N N
Partical size:X97 Not more than10.0 0 Character N N N
Particle below 20# Sieve 0 Character N N N
Particle below 60# Sieve 0 Character N N N
Particle Size 0 Character N N N
Particle size (By Malvern)-D10 0 Character N N N N
Particle size (By Malvern)-D50 0 Character N N N N
Particle size (By Malvern)-D90 0 Character N N N N
Particle Size (by sieve) 0 Character N N N
Particle Size - D97 0 Character N N N N
Particle Size : X95 0 Character N N N N
Particle Size Distribution (Estimation by analytical sieving) 0 Character N N N
Particle Size-D90 0 Character N N N N
Particle size: 0 Character N N N
Particle size: By Diffraction ( D10 ) 0 Character N N N
Particle size: By Diffraction (D50) 0 Character N N N
Particle size: By Diffraction (D90) 0 Character N N N
Particle size: By Diffraction (D97) 0 Character N N N
Particles ≥ 10µm 0 Character N N N N
Particles ≥ 25µm 0 Character N N N N
Particles≥10pm 0 Character N N N
Particles≥25pm 0 Character N N N
Particulate contamination Equal to greater than 10µm 0 Character N N N N
Particulate contamination Equal to or greater than 25 µm 0 Character N N N N
Particulate Matter NMT 6000 0 Character N N N
Particulate Matter (per gm) 0 Character N N N
Pasting / pre folding 0 Character N N N N
Pasting Quality 0 Character N N N
Pathogens 0 Character N N N
Peel Test 0 Character N N N
Penetrability 0 Character N N N
Performance test 0 Character N N N
Peroxide value 0 Character N N N
Peroxides 0 Character N N N
pH 0 Character N N N
pH ( 10% w/w ) 0 Character N N N
pH ( 2.0 g in 10 ml ) 0 Character N N N
pH (1.0g in 10ml) 0 Character N N N
pH (100 mg of Cefepime per ml) 0 Character N N N
pH (100 mg/ml ) 0 Character N N N
pH (125 g Sulbactam/ml and 250mg cefoperazone/ml) 0 Character N N N N
pH (5 % w/v aqueous solution.) 0 Character N N N
pH (5.0 % w/v suspension in carbon dioxide free water ) 0 Character N N N
pH (Determine in solution A) 0 Character N N N
pH * 0 Character N N N
PH AFTER 7 DAYS 0 Character N N N
pH of 2% Slurry 0 Character N N N
Pharma code No. 0 Character N N N
Pharmacode value 0 Character N N N
Physical Test White and Black Spot should be absent. Top layer of aluminium should not leech/scratch while rubbing 0 Character N N N
Piercing 0 Character N N N
Pin hole count (Nos) * 0 Character N N N
Pin hole count (Nos)* 0 Character N N N
Pin Holes 0 Character N N N
PLAIN CARTON 0 Character N N N
Plug Diameter Plug Diameter 0 Character N N N
Plunger top Diameter 0 Character N N N
Poly foil gsm 0 Character N N N
Poly Gsm 0 Character N N N
Polyamide 0 Character N N N
Polymorphic Identity : By X-Ray Powder Diffraction 0 Character N N N
Potassium 0 Character N N N
Potassium :By flame photometry and atomic absorption spectrophotometry 0 Character N N N
Povidone (PVPK-30) IP 0 Character N N N
Powder fineness(By sieve) 0 Character N N N
Presence of Dirt and Stain 0 Character N N N
Preservative Content 0 Character N N N
Print quality 0 Character N N N
Print repeat length 0 Character N N N
Printability 0 Character N N N
PRINTED POUCH & LAMINATED (LUPIN ) 0 Character N N N
PRINTED POUCH ST LABEL 65 X48 MM 0 Character N N N
Printed text matter 0 Character N N N
Printing 0 Character N N N
Printing Color 0 Character N N N
Printing Matter 0 Character N N N
Printing Quality 0 Character N N N
Printing Surface 0 Character N N N
Propanol 0 Character N N N
Protein 0 Character N N N
Proteinous Impurities 0 Character N N N
pseudomonas aeruginosa 0 Character N N N
Purity: By HPLC 0 Character N N N
PVC 0 Character N N N
PVC BY Morpholine 0 Character N N N
PVC Flim 0 Character N N N
PVC with Adhesive 0 Character N N N
PyrBulk Density 0 Character N N N
Pyridine Content (By HPLC) 0 Character N N N
Pyruvic Acid 0 Character N N N
Q. E-Cefdinir 0 Character N N N
R. Cefdinir decarboxy open ring Lactone a 0 Character N N N
Ratio of Alkyl components. (By: HPLC.) n-C12H25 homolog 0 Character N N N
Reactions of bromides-(A): 0 Character N N N N
Reactions of bromides-(B): 0 Character N N N N
Readily cabonisable substances 0 Character N N N
Readily Oxidisable Substances 0 Character N N N
Reconstitution Time Seconds 0 Character N N N
Reconstitution Time (Seconds) 0 Character N N N
Redispersibility 0 Character N N N
Reducing Impurities 0 Character N N N
Reducing Impurity Not more than 5.0 ml of 0.01 M ceric ammonium sulphate is required. 0 Character N N N
Reducing substances 0 Character N N N
Reducing sugars 0 Character N N N
Reflect Embossing 0 Character N N N
Refractive index 0 Character N N N
Refractive Index @20 ºC º 0 Numeric Range N N N
Related Compound -A 0 Character N N N
Related Compound -B 0 Character N N N
Related Density 0 Character N N N
Related Substance By HPLC (%) 0 Character N N N
Related substances (By UPLC) 0 Character N N N N
Related Substances : (By Thin Layer Chromatography) 0 Character N N N
Related Substances: (By HPLC) i) Ciprofloxacin ethylene diamine analog 0 Character N N N
Related Substances: (By HPLC) ii) Any other Individual impurity 0 Character N N N
Related Substances: (By HPLC)iii) Sum of all Impurities 0 Character N N N
Related Substances: Any secondary peak 0 Character N N N
Related Substances: By HPLC (For Budesonide) 11-Keto Budesonide Impurity 0 Character N N N N
Related Substances: By HPLC (For Budesonide) 21-dehydro budesonide Impurity 0 Character N N N N
Related Substances: By HPLC (For Budesonide) Single maximum unknown Impurity 0 Character N N N N
Related Substances: By HPLC (For Budesonide) Total Impurities 0 Character N N N N
Related Substances: By HPLC (For Formoterol) Formoterol Amine Impurity 0 Character N N N N
Related Substances: By HPLC (For Formoterol) Single Maximum Unknown Impurity 0 Character N N N N
Related Substances: By HPLC (For Formoterol) Total Impurity 0 Character N N N N
Related Substances: By HPLC (Any individual impurity) 0 Character N N N
Related Substances: By HPLC (Total impurity) 0 Character N N N
Related Substances: By HPLC Single maximum impurity 0 Character N N N
Related Substances: Sum of all secondary peaks 0 Character N N N
Relative content of Stearic acid and Palmitic acid (GC Analysis) 0 Character N N N
Relative Density 0 Character N N N
Relative Index 0 Character N N N
Release Paper 0 Character N N N
repeat length 0 Character N N N
Residual Solvent 0 Character N N N
Residual Solvent (by GC) Ethanol 0 Character N N N N
Residual Solvent (By GC) Isopropyl Alcohol Methonol 0 Character N N N N
Residual solvent (Ethyl acetate) 0 Character N N N
Residual solvent by GC (Acetone) Not More Than 5000 0 Character N N N
Residual solvent By GC (Methylene dichloride) Not More Than 600 0 Character N N N
Residual solvent by GC(Acetonitrile) Not More Than 410 0 Character N N N
Residual solvent by GC(Butyraldehyde) Not More Than 100 0 Character N N N
Residual Solvent By GC(Ethyl Acetate) Not More Than 5000 0 Character N N N
Residual solvent By GC(Methanol) Not More Than 1000 0 Character N N N
Residual Solvent Methylene Chloride 0 Character N N N
Residual solvent: (By GC) 2) n-Butanol 0 Character N N N
Residual solvent: (By GC) Methanol 0 Character N N N
Residual solvent: (By GC) Toluene 0 Character N N N
Residual solvent: Acetone 0 Character N N N
Residual solvent: Acetonitrile 0 Character N N N
Residual solvent: Butyraldehyde 0 Character N N N
Residual solvent: Methanol 0 Character N N N
Residual solvent: Methylene dichloride 0 Character N N N
Residual solvent: By :GC Di isopropyl ether 0 Character N N N
Residual Solvent: BY GC Tetrahydrofuran 0 Character N N N
Residual Solvents (By GC) Diethyl ether 0 Character N N N N
Residual Solvents (By GC) Methyl ethyl ketone 0 Character N N N N
Residual solvents (ppm) i)1,4 Dioxane 0 Character N N N
Residual solvents : Name of manufacturer : FEF chemicals 0 Character N N N
Residual solvents :Name of manufacturer: canton laboratories Pvt.Ltd., 0 Character N N N
Residue on evaporation 0 Character N N N
Residue on Ignition 0 Character N N N
Resin 0 Character N N N
Retained on 40# Mesh 0 Character N N N
Retained on 80# Mesh 0 Character N N N
Revision History 0 Character N N N
Rim Thickness 0 Character N N N
Rivision History 0 Character N N N
Roll outer diameter 0 Character N N N N
Rub Resistence 0 Character N N N
S-Methyl Fluticasone 0 Character N N N N
S. Cefdinir decarboxy open ring Lactone b 0 Character N N N
Salmonell sp. 0 Character N N N
Salmonella 0 Character N N N
Saponification value 0 Character N N N
Scuff Proof 0 Character N N N
Scuff Test 0 Character N N N
Sealing Quality 0 Character N N N
Second substrate (PE) GSM 0 Character N N N
Security measures 0 Character N N N
Self Sealing Test 0 Character N N N
Self-Sealiability 0 Character N N N
Settling volume 0 Character N N N
Shade 0 Character N N N
Shigella 0 Character N N N
Shore a Hardness 0 Character N N N
Sieve Analysis 0 Character N N N
Sieve analysis (#% Fines through 60#) % 0 Numeric Range N N N N
Sieve Analysis (#40) 0 Character N N N
Sieve analysis by 30 mesh 0 Character N N N
Single Maximum Impurity 0 Character N N N N
Single Maximum unknown impurity (%): 0 Character N N N
Size of Box 0 Character N N N N
Slot Size 0 Character N N N
Sodium 0 Character N N N
SODIUM BISULPHITE 0 Character N N N
SODIUM BISULPHITE -IP 0 Character N N N
Sodium carbonate (%w/w) * 0 Character N N N
Sodium carbonate content (By Titration) 0 Character N N N
Sodium chloride 0 Character N N N
Sodium chloride & sodium sulphate 0 Character N N N
Sodium chloride and sodium Glycollate (on dried basis) 0 Character N N N
Sodium Chloride IP 0 Character N N N
Sodium Glycollate 0 Character N N N
Solubility 0 Character N N Y
Solubility ammonical solution of copper tetrammine 0 Character N N N
Soluble Chloride & Sulphate (As sodium Salt) 0 Character N N N
Solution S 0 Character N N N
Special Instruction 0 Character N N N
Specific Absorbance 0 Character N N N
Specific Gravity g/ml 0 Character N N N
Specific Optical Rotation (°) 0 Character N N N
Specific Optical Rotation (o) (Calculate on Anhydrous basis) 0 Character N N N
Specific optical rotation: calculated on dried basis. 0 Character N N N
Specific rotation 0 Character N N N
Spoon Cup Height (mm) 0 Character N N N
Spoon Handle Width (mm) 0 Character N N N
Spoon Total Length (mm) 0 Character N N N
Stability of Suspension (After 4 days) 0 Character N N N
Standard Packing 0 Character N N N
Staphylococcus aureus 0 Character N N N
Starch 0 Character N N N
Starch & dextrins 0 Character N N N
Stearic acid 0 Character N N N
Stearic acid and Palmitic acid 0 Character N N N
Stearic acid: 0 Character N N N N
Sterile Ceftriaxone Sodium IP Eq. to Ceftriaxone % 0 Numeric Range N N N
Sterile Tazobactam Sodium Eq.to Tazobactam % 0 Numeric Range N N N
Sterility 0 Character N Y N
Sterility Test 0 Character N N N
Sterility(Membrane filtration method) 0 Character N Y N
Sterilization test 0 Character N N N
Sticking 0 Character N N N
Storage Condition 0 Character N N N
Sulbactam 0 Character N N N N
Sulbactam Related Compound A 0 Character N N N
Sulbactam Related Compound B 0 Character N N N
Sulbactam Related Compound C 0 Character N N N
Sulbactam Related Compound D 0 Character N N N
Sulbactam Related Compound E 0 Character N N N
Sulbactam Related Compound F 0 Character N N N
Sulbactam Sodium BP Eq. to au Sulbactam. 0 Character N N N
Sulbactam Sodium IP Eq. to Sulbactam 0 Character N N N
Sulbactam Sodium IP Eq.to Sulbactam 0 Character N N N
Sulbactam Sodium USP Eq.to Anhydrous Sulbactam % 0 Numeric Range Y N N
Sulbactam Sodium USP Eq.to Sulbactam 0 Character N N N
Sulfate 0 Character N N N
Sulfites 0 Character N N N
Sulfur dioxide 0 Character N N N
Sulphate content 0 Character N N N
Sulphated Ash 0 Character N N N
Sulphated Ash (% w/w) 0 Character N N N
Sulphated Ash (on dried basis) 0 Character N N N
Sulphates 0 Character N N N
Sulphite 0 Character N N N
Sulphites 0 Character N N N
Sum of all secondary impurity 0 Character N N N
Sum of impurities B and C 0 Character N N N
Sum of Impurities other than A and B 0 Character N N N
Sum of impurities other than A and C 0 Character N N N
Supply: 0 Character N N N
Surface finish 0 Character N N N
Surface Glass Test(ml) 0 Character N N N
T-1551B 0 Character N N N N
T-1551E 0 Character N N N N
T-1551F 0 Character N N N N
T. Cefdinir impurity 3 0 Character N N N
Tagger Diameter 0 Character N N N
Tagger Thickness 0 Character N N N
TAMC (Total aerobic microbial count) 0 Character N N N
Tap density 0 Character N N N N
Taped Bulk Density 0 Character N N N
Tapped density 0 Character N N N
Tartrates 0 Character N N N
Taste 0 Character N N N
Tazobactam on anhydrous basis 0 Character N N N
Tazobactam Sodium eq. to Tazobactam 0 Character N N N
Tazobactam Sodium Eq.to Tazobactam % 0 Numeric Range N N N
Tazobactam Sodium on anhydrous basis 0 Character N N N
Technical Defects 0 Character N N N
Test 0 Character N N N
testA 0 Character N N N N
Tetradecane 0 Character N N N N
Tetrahydrofuran 0 Character N N N
Text Matter 0 Character N N N
Text Matter& colour 0 Character N N N
The average volume of suspension should not be less than 100% of the volume declared in the labeling. (NLT 30 ml) 0 Character N N N
Thiazolylglyoxalic methyloxime 0 Character N N N
Thickness 0 Character N N N
Thickness (mm) 0 Character N N N
Thickness of alu. foil 0 Character N N N
Thickness of Aluminium (mm) 0 Character N N N
Thickness of Aluminium Wall (mm) 0 Character N N N
Thickness of BOPP 0 Character N N N
Thickness of metalized polyester film 0 Character N N N
Thickness of polyester film 0 Character N N N
Thickness of polythene 0 Character N N N
Thickness Of Wad(mm) 0 Character N N N
Thickness off sheet (mm) 0 Character N N N
Third substrate (Al foil) GSM 0 Character N N N
Thread Dia (mm) 0 Character N N N
Titanium 0 Character N N N
Toluene 0 Character N N N
Top Diameter 0 Character N N N
Top Layer 0 Character N N N
Top Outer Diameter 0 Character N N N
Total Aerobic Microbial Count NMT 103 cfu/ml 0 Character N N N
Total Aerobic Microbial Count (TAMC) 0 Character N N N
Total Aerobic Microbial Count NMT 1000 cfu/ml 0 Character N N N
Total aerobic microbial count . Not more than 1000 cfu per g 0 Character N N N
Total Ash (%) 0 Character N N N
Total bacterial count 0 Character N N N
Total combined molds and Yeasts count 0 Character N N N
Total combined yeast and molds count 0 Character N N N
Total combined Yeasts and Molds Count NMT 102 cfu/ml 0 Character N N N
Total combined yeasts and molds count . Not more than 100 cfu per g 0 Character N N N
Total combined Yeasts and Molds Count NMT 100 cfu/ml 0 Character N N N
Total degradation product 0 Character N N N
Total degradation product. 0 Character N N N
Total degradation products(excluding Glycopyrrolate related compound C) 0 Character N N N N
Total Dye Content 0 Character N N N
Total Ethanol and Water: The sum of the percentage of Ethanol and the percentage water 0 Character N N N
Total fungi and yeast count 0 Character N N N
Total fungi count 0 Character N N N
Total Gramage Of Aluminium Foil with VMCH/HSL/Universal HSL 0 Character N N N
Total Grammage 0 Character N N N
Total Grammage of Laminate (g/m2) 0 Character N N N N
Total Grammage Of Aluminum Foil 0 Character N N N
Total GSM 0 Character N N N
Total Height 0 Character N N N
Total Height (mm) 0 Character N N N
Total Hight 0 Character N N N
Total Impurities 0 Character N N N
Total Impurities (excluding 0 Character N N N
Total Impurities (excluding Compound A (Aminosulfinic acid) 0 Character N N N
Total impurities other than Ethanol and 2-methylbut -2-ene 0 Character N N N
Total Impurity 0 Character N N N
Total Organic Carbon NMT 8000 ppb. 0 Character N N N
Total secondary Impurities 0 Character N N N
Total Thickness 0 Character N N N
Total unknown impurity (%) 0 Character N N N
Total viable microbial count 0 Character N N N N
Total Weight (mg) 0 Character N N N
Total Weight (gm) 0 Character N N N
Total Yeast and Mold Count (TYMC) 0 Character N N N
Total Yeasts and Molds Count Tests for Specified Micro-Organisms: 0 Character N N N
Transmittance 0 Character N N N
Triethyamine 0 Character N N N
Triethylamine 0 Character N N N
Truxone 1.0 g Sticker label 0 Character N N N
Type 0 Character N N N
Type Of Carton 0 Character N N N
Type of Container 0 Character N N N
Type of flute 0 Character N N N
Type of Varnish 0 Character N N N
Undecane 0 Character N N N N
Uniformity of content 0 Character N N N N
Uniformity of Dispersion 0 Character N N N
Uniformity of dosage units (By weight variation) 0 Character N N N
Uniformity of dosage units By Content Uniformity 0 Character N N N
Uniformity of net filled weight 0 Character N N N
Uniformity of Volume 0 Character N N N
Uniformity of weight 0 Character N N N
Uniformity of weight Fill weight (Average) (20 vial) 0 Character N N N N
Unsaponifiable Matter (%w/w) 0 Character N N N
Unspecified Impurities 0 Character N N N
Unsulfonated primary aromatic amine (Calculated as Aniline) 0 Character N N N
Untaped Bulk Density 0 Character N N N
Unwinding direction 0 Character N N N
User Test 0 Character N N N
v)Dichloro methane 0 Character N N N
Validation 0 Character N N N
Varnish 0 Character N N N
Varnish Details 0 Character N N N
Varnish Grade 0 Character N N N
vi)Ethyl Acetate 0 Character N N N
vii)Methyl isobutyl ketone 0 Character N N N
viii)N-Butyl acetate 0 Character N N N
Vinylpyrrolidinone. 0 Character N N N
Viscosity 0 Character N N N
Viscosity by Rotational Methods mPa.s 0 Character N N N
Visible 0 Character N N N
Visual defects* 0 Character N N N
Visual Foreign Matter 0 Character N N N
Visual Inspection 0 Character N N N
Visual Inspection* 0 Character N N N
Visual Test 0 Character N N N
VMCH Coating 0 Character N N N
VMCH GSM 0 Character N N N
Volatile matter 0 Character N N N
Volatile Oil Content 0 Character N N N
Volatile Sulphides 0 Character N N N
Volume check 0 Character N N N
Volume in Container 0 Character N N N N
wad density 0 Character N N N
Wall Thickness 0 Character N N N
Water Not more than 3.00% w/w 0 Character N N N
Water (% W/W) 0 Character N N N
Water (% w/w) (Use 0.5 g of sample) 0 Character N N N
Water (% W/W) (Use 1.0 g of Sample) 0 Character N N N
Water (%w/w) (Use 0.4 g of sample). 0 Character N N N
Water (%w/w). (Use 0.3g of sample)* 0 Character N N N
Water (%w/w).(Use 0.15gm of sample) 0 Character N N N
Water (KF) 0 Character N N N N
Water (Method I) 0 Character N N N
Water by KF ( % w/w) 0 Character N N N
Water by KF ( % w/w) (Use 0.2g sample). 0 Character N N N
Water by KF (%w/w) (Use 0.1g sample) 0 Character N N N
Water Content 0 Character N N N
Water Content (%w/w) (Determined on 0.5 g) 0 Character N N N
Water determination 0 Character N N N
Water insoluble matter 0 Character N N N
Water soluble substances 0 Character N N N
Water-insoluble matter 0 Character N N N
Water-soluble substances 0 Character N N N
Water: By Karl Fischer 0 Character N N N
Weight 0 Character N N N
Weight (g) 0 Character N N N
Weight of without wad (g) 0 Character N N N
Weight Of 10Flip Off Seal (gm) 0 Character N N N
Weight Of Wad (GM) 0 Character N N N
Weight per ml 0 Character N N N
Weight per ml@20ºC 0 Numeric Range N N N
Weight-Of Tagger (Wad) 0 Character N N N
Width 0 Character N N N
Width (mm) 0 Character N N N
Width After Folding 0 Character N N N N
Width of folding 0 Character N N N
Width of Partition 0 Character N N N
Winding 0 Character N N N
Winding direction 0 Character N N N
winding of Roll 0 Character N N N
Yeast & Mold/G 0 Character N N N
Yeast and Mould Count 0 Character N N N
Zinc stearate 0 Character N N N
ZPL Validation Test Validation Test 0 Character N N N